Please use this identifier to cite or link to this item: https://doi.org/10.1111/j.1471-4159.2006.04215.x
Title: Novel modulators of amyloid-β precursor protein processing
Authors: Tang, B.L. 
Liou, Y.C. 
Keywords: Alzheimer's disease
Amyloid-β
Munc-18 interacting proteins
Nogo
Pin1
Rho
Issue Date: Jan-2007
Citation: Tang, B.L., Liou, Y.C. (2007-01). Novel modulators of amyloid-β precursor protein processing. Journal of Neurochemistry 100 (2) : 314-323. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1471-4159.2006.04215.x
Abstract: Proteolytic processing of the amyloid precursor protein (APP) is modulated by the action of enzymes α-, β- and γ-secretases, with the latter two mediating the amyloidogenic production of amyloid-β (Aβ). Cellular modulators of APP processing are well known from studies of genetic mutations (such as those found in APP and presenilins) or polymorphisms (such as the apolipoprotein E4 ε-allele) that predisposes an individual to early or late-onset Alzheimer's disease. In recent years, several classes of molecule with modulating functions in APP processing and Aβ secretion have emerged. These include the neuronal Munc-18 interacting proteins (Mints)/X11s, members of the reticulon family (RTN-3 and RTN-4/Nogo-B), the Nogo-66 receptor (NgR), the peptidyl-prolyl isomerase Pin1 and the Rho family GTPases and their effectors. Mints and NgR bind to APP directly, while RTN3 and Nogo-B interact with the β-secretase BACE1. Phosphorylated APP is a Pin1 substrate, which binds to its phosphor-Thr668-Pro motif. These interactions by and large resulted in a reduction of Aβ generation both in vitro and in vivo. Inhibition of Rho and Rho-kinase (ROCK) activity may underlie the ability of non-steroidal anti-inflammatory drugs and statins to reduce Aβ production, a feat which could also be achieved by Rac1 inhibition. Detailed understanding of the underlying mechanisms of action of these novel modulators of APP processing, as well as insights into the molecular neurological basis of how Aβ impairs leaning and memory, will open up multiple avenues for the therapeutic intervention of Alzheimer's disease. © 2007 The Authors.
Source Title: Journal of Neurochemistry
URI: http://scholarbank.nus.edu.sg/handle/10635/77544
ISSN: 00223042
DOI: 10.1111/j.1471-4159.2006.04215.x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

45
checked on Aug 17, 2018

WEB OF SCIENCETM
Citations

43
checked on Jul 9, 2018

Page view(s)

68
checked on Jun 8, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.